Genomics England today announced the successful companies in its Small Business Research Initiative (SBRI) Phase Two assessment of Enabling Technologies for Genomics Sequence Data Analysis and Interpretation. £8 million is being made available for the product development stage of the competition with the companies adopting a programme of 12 to 24 months each. This competition […]
Oxford Gene Technology (OGT), the molecular genetics company, today announced it has been awarded a £1.2m phase two Small Business Research Initiative (SBRI) Healthcarecontract. The contract is to develop Next Generation Sequencing (NGS) analysis software, following the successful completion of phase one and an evaluation by Genomics England, UK Department of Health and Innovate UK. […]
LONDON –– Seven Bridges Genomics UK, Ltd. today announced it will receive approximately £1.95 million to complete and launch the world’s first functional Graph Genome reference and suite of related tools, thanks to a Small Business Research Initiative grant from the UK Department of Health and Genomics England. The Graph Genome is a revolutionary tool […]
PROVO, Utah -– Tute Genomics, pioneer in affordable, accurate and rapid genome interpretation, has been selected by next-generation sequencing company PrimBio Research Institute to be its primary provider of whole exome and targeted gene panel interpretation. PrimBio, a certified Life Technologies Ampliseq Exome sequencing provider, has adopted the most current technologies to support the work […]
MOSCOW — Illumina, Inc. (NASDAQ:ILMN) today announced it has extended its distribution channel through a new relationship with Albiogen Ltd., a life science distributor that specializes in next-generation sequencing (NGS), headquartered in Moscow. Albiogen will expand the reach of Illumina’s array of next-generation sequencing platforms and solutions across the Russian Federation and Commonwealth of Independent […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight® HLA, a complete, end-to-end solution that produces a comprehensive view of the HLA region by sequencing 11 HLA genes for accurate HLA typing across thousands of known and novel HLA alleles. Leveraging the MiSeq® Sequencing System, the kit includes the TruSight HLA Sequencing […]
BOULDER, Colo. — ArcherDX today launched new versions of its Archer™ Suite of software programs, consisting of Analysis 3.1, Assay Designer 2.0 and Quiver 1.0.2. “The Archer™ Suite is a critical component of ArcherDX’s NGS applications. This free software suite is purpose-built to provide our customers powerful and easy-to-use programs to take full advantage of […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that its Single Molecule, Real-Time (SMRT®) Sequencing was featured in a number of presentations during last week’s Advances in Genome Biology & Technology (AGBT) conference, including demonstrations of the technology’s ability to create reference-quality de […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today launched two new products—the HaloPlexHS target enrichment system and ClearSeq Comprehensive Cancer research panel—designed to improve the speed and accuracy of clinical cancer research. Both products will enable researchers to rapidly and accurately identify disease-associated variants in tumor samples—information that can be vital to research […]
SAN FRANCISCO — Illumina, Inc. (NASDAQ:ILMN) today announced its new Illumina Accelerator Boost Capital has secured an initial capital commitment of $40 million from Viking Global Investors, a privately owned, global investment firm. Capital commitments made to Illumina Accelerator Boost Capital will be used to fund investments in promising genomic startups that graduate from Illumina […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
